Sentinel lymph node mapping identifies positive lymph nodes in women with high-risk endometrial cancer, MD Anderson study finds
Research offers promise for less invasive staging tool, future management of disease
MD Anderson News Release 03/31/2015
In a study of women with high-grade endometrial cancer, researchers at The University of Texas MD Anderson Cancer Center, found sentinel lymph node (SLN) mapping accurately identified all women with node-positive, high-risk endometrial cancer, when prospectively compared to a complete pelvic and...
Cancer immunotherapy innovator Jim Allison wins 2015 Paul Ehrlich and Ludwig Darmstaedter Prize
MD Anderson News Release 03/16/2015
Jim Allison, Ph.D., chair of Immunology at The University of Texas MD Anderson Cancer Center, received...
MD Anderson study predicts new hepatitis C drugs will place a dramatic financial strain on the health care system
MD Anderson News Release 03/16/2015
NOTE TO MEDIA: This study was finalized prior to FDA approval of AbbVie’s HCV drug, and of...
Hippo ‘Crosstalk’ May Be Vital to Tumor Suppression
MD Anderson Study Reveals New Understanding of Key Cell-Signaling Pathway
MD Anderson News Release 03/09/2015
Think of a waterfall, and you might see why cell-signaling pathways are important to cancer research. As water cascades, it impacts everything downstream. And everything upstream affects the waterfall.
Cell-signaling pathways are similar in that one molecular action results in another, and another, ultimately...
MD Anderson Study Shows Why Some Brain Cancers Resist Treatment
MD Anderson News Release 03/02/2015
Scientists at The University of Texas MD Anderson Cancer Center may have discovered why some...